Chemoinformaics analysis of TETRACOSADIENOIC-ACID
| Molecular Weight | 368.646 | nRot | 22 |
| Heavy Atom Molecular Weight | 320.262 | nRig | 1 |
| Exact Molecular Weight | 368.365 | nRing | 0 |
| Solubility: LogS | -6.754 | nHRing | 0 |
| Solubility: LogP | 9.98 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 73.6901 |
| nHD | 1 | BPOL | 49.0219 |
| QED | 0.194 |
| Synth | 1.667 |
| Natural Product Likeliness | 0.267 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -5.196 |
| MDCK | 0.0000104 |
| BBB | 0.007 |
| PPB | 0.98901 |
| VDSS | 1.515 |
| FU | 0.00684012 |
| CYP1A2-inh | 0.102 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.214 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.995 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.026 |
| CYP3a4-inh | 0.071 |
| CYP3a4-sub | 0.007 |
| CL | 2.761 |
| T12 | 0.21 |
| hERG | 0.199 |
| Ames | 0.005 |
| ROA | 0.012 |
| SkinSen | 0.957 |
| Carcinogencity | 0.03 |
| EI | 0.923 |
| Respiratory | 0.843 |
| NR-Aromatase | 0.11 |
| Antiviral | No |
| Prediction | 0.569773 |